Autoyos Private Limited
iRobo is an autonomous system for rapid eye diagnostics.
iRobo is a rapid eye diagnostics technology that is fully autonomous. The iRobo aims to provide comprehensive eye care in non-clinical settings and can be operated by non-skilled professionals. The device uses artificial intelligence to detect early stages of noncommunicable diseases such as diabetes mellitus, cardiovascular diseases, stroke, and Alzheimer’s Disease. The product provides automated screening, remote diagnosis, and robotic treatment enabled by machine learning without requiring an operator.
Product is still in the prototyping phase.
Goal 3: Good health and well-being
Health care workers at eye clinics, hospitals, and eyewear stores
The product is manufactured in India.
The product is still in its early phases and not commercially available. However it will be distributed through distributor channels and strategic partners. Interview with designer, July 2020
50 products have been distributed as of July 2020Interview with designer, July 2020
The iRobo is a fully autonomous system with several components. The key characteristics of the product are: it is non-invasive, it generates a computerized screening report, it’s autonomous features removes operator variability and the need for a skilled operator, a remote diagnosis can be provided, no pupil dilation required, and it offers real time audio guidance.
Provided by the manufacturer.
Manufacturer specified performance targets include: quick, user comfort, accuracy of readings, and high image quality.
TUV Rheinland performed a safety standard test.
S. Marmamula, J. E. Keeffe, U. Raman, and G. N. Rao, Population-based cross-sectional study of barriers to utilisation of refraction services in South India: Rapid Assessment of Refractive Errors (RARE) study, BMJ Open, vol. 1, no. 1, p. e000172, Jan. 2011, doi: 10.1136/bmjopen-2011-000172.
J. S. Rahi, S. Sripathi, C. E. Gilbert, and A. Foster, Childhood blindness in India: Causes in 1318 blind school students in nine states, Eye, vol. 9, no. 5, pp. 545–550, 1995, doi: 10.1038/eye.1995.137.
P. Keane and E. Topol, Reinventing the eye exam, Lancet, vol. 394, no. 10215, p. 2141, Dec. 2019, doi: 10.1016/S0140-6736(19)33051-X.
IEC and ISO standards were considered in the design. IEC safety tests will be performed to ensure product safety.
Safety testing, clinical trials
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.